Molecular Wellness Testing. Powered by Biomeme.
The same platform that identifies biological threats and distinguishes bacterial from viral infections can now monitor your molecular response to therapy — in real time.
Your genes don't change. But gene expression does — every day, in response to medication, diet, stress, and disease. We measure it.
Three Verbs. One Platform.
Transcriptomic wellness testing isn't a single snapshot. It's a longitudinal molecular journey.
Predict
Know how your body is likely to respond before starting a treatment. Genetic markers flag predispositions. Expression baselines establish your starting point.
Confirm
Verify the treatment is engaging molecular targets — don't wait months for clinical results. Gene expression changes appear weeks before weight, labs, or symptoms shift.
Monitor
Detect molecular drift before clinical symptoms appear. Longitudinal monitoring catches treatment fatigue, regain risk, and response changes early — so you can adapt proactively.
One Platform. Many Applications.
From deep whole-transcriptome sequencing in our CLIA laboratory to targeted molecular assays, Biomeme's platform captures how your biology responds over time across key health domains.
Inflammation Compass
Whole-blood transcriptomic profiling across three independent Health Domains: Activation, Antiviral Response, and Resolution. Tracking how your immune system responds to protocols without crude composite scores.
Founding cohort open
GLP-1 / Weight Management
Inflammatory resolution, lipogenic suppression, metabolic adaptation. Predict, confirm, and monitor GLP-1 therapeutic response at the molecular level.
Founding cohort open
Peptide Therapy
BPC-157, Thymosin Beta-4, and other therapeutic peptides. Track tissue repair markers and inflammatory response to confirm peptide efficacy at the molecular level.
Signature in development
Hormonal Health
HPA axis markers, thyroid response genes, cortisol signaling. Monitor how hormonal interventions are engaging at the transcriptomic level.
Use case under evaluation
Dermatology
Skin barrier gene expression, inflammatory cascades, and treatment response markers for conditions like eczema, psoriasis, and chronic inflammatory skin disease.
Use case under evaluation
Metabolic Health
Insulin signaling, lipid metabolism, and mitochondrial function. A comprehensive metabolic snapshot beyond standard blood panels — catching shifts weeks before traditional markers move.
Use case under evaluation
How Molecular Monitoring Works
A seamless, end-to-end pipeline from sample collection to actionable biological insight.
PAXgene Collection
Standard venous blood draw into a PAXgene RNA tube, stabilizing cellular transcriptomes at room temperature.
High-Depth Sequencing
Processed at One Health Labs (CLIA) via Illumina NovaSeq high-depth paired-end RNA sequencing (~30M read pairs).
Domain-Resolved Scoring
Rank-based module scoring across 3 Health Domains (Activation, Antiviral, Resolution) with deliberately no composite score.
Actionable Trajectory
Longitudinal reporting compares repeat tests (1, 3, 12 months) directly against your personal baseline with clinician guidance.
The Biomeme Molecular Ecosystem
Comprehensive wellness profiling bridges two essential molecular capabilities: high-depth whole-transcriptome sequencing in our CLIA laboratory and deployable real-time instrumentation for point-of-care intelligence.
As Biomeme's dedicated clinical testing arm, One Health Labs processes whole-blood RNA sequencing panels (such as Inflammation Compass) on Illumina NovaSeq instruments, delivering high-depth paired-end resolution across thousands of genes.
Alongside central lab sequencing, Biomeme's portable real-time PCR hardware (the Biomeme/5) provides decentralized molecular testing for targeted point-of-care applications.
Why Transcriptomics?
Unlike static genetic tests that tell you what you were born with, transcriptomic markers change in real time — giving you a molecular snapshot of what's happening right now.
Gene expression responds to medication, diet, stress, and disease weeks before traditional blood panels, weight measurements, or clinical symptoms change. That's not a marginal improvement — it's a fundamentally different category of insight.
Learn About TranscriptomicsGenomics
Static
What you have
Transcriptomics
Dynamic
What's active
Proteomics
Slow
Lab only
Have a Use Case? Let's Build It.
We partner with researchers, therapeutics companies, and clinical organizations to develop custom transcriptomic signatures on our platform. If you have a therapeutic area that needs molecular monitoring, we'd love to talk.
Assay development — We design multiplexed panels for your target analytes.
Validation support — CLIA-certified lab for clinical validation and testing.
Full deployment — From signature development to consumer-facing dashboard and reporting.
"The future of wellness is proactive. Proactive health demands precision insights. Precision insights demand transcriptomics. And transcriptomics is powered by Biomeme."
The Biomeme Wellness Thesis
Explore Our Scoring Hubs
Proprietary evidence-based scoring that cuts through the noise.
GLP-1 Response Predictor
Compare Ozempic, Wegovy, Mounjaro, and more across 5 evidence dimensions.
Peptide Evidence Score
How well-evidenced is your stack? Honest, transparent grading of BPC-157, NAD+, and more.
Inflammation Evidence Score
Objective grading of eight circulating biomarkers across 4 clinical evidence dimensions.
Clinical Partners
Track Your Inflammation — Cohort Now Forming
Real mRNA data on whether your anti-inflammatory protocol or therapy is working. Reserve your spot in the Inflammation Compass founding cohort today to lock in early pricing before the general public.